STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2842 by analyst upside · 2026-06-27
AFYA
Afya Limited
Consumer Defensive · Market Cap $1B · P/E 9.3x
ANALYST PRICE TARGET
+11.3%
implied upside to consensus target
Current Price $14.87
Consensus Target $16.55
Bull Target $20.85
Bear Target $14.38
Analysts Covering 9
ANALYST CONSENSUS — HOLD
Strong Buy
1
Buy
0
Hold
5
Sell
3
52-Week Low $13.0
52-Week High $18.16
YTD Return +3.9%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 9.3x
Forward P/E 7.6x
EPS (TTM) $1.60
PEG Ratio N/A
Dividend Yield 4.46%
Revenue (TTM) $3.8B
Profit Margin 20.1%
52-WEEK RANGE
52-Week Low $13.0
52-Week High $18.16
Current Price $14.87
Bear Target $14.38
Bull Target $20.85
● Now $14.87 ● Target $16.55
TRADING DATA
Avg Volume 94K
YTD Return +3.9%
Analyst Count 9
Consensus Hold
Upside to Target +11.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Afya Limited (AFYA) is currently trading at $14.87 with a Wall Street consensus price target of $16.55, implying potential upside of 11.3% over the next 12 months. 9 analysts currently cover AFYA, with a consensus rating of Hold — 11% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.85, while the most cautious has a target of $14.38.

AFYA operates in the Consumer Defensive sector with a market capitalisation of $1B. The stock is up 3.9% year-to-date and is currently trading near the lower end of its 52-week range of $13.0 – $18.16.

SIMILAR STOCKS

Other Consumer Defensive stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for AFYA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan — Reiterated
Neutral → Neutral 2026-04-30 43% win rate (7 calls)
B of A Securities ↓ Downgrade
Buy → Neutral 2026-02-24 Building track record
Morgan Stanley ↓ Downgrade
Equal-Weight → Underweight 2026-02-13 Building track record
UBS ↓ Downgrade
Buy → Neutral 2026-01-16 33% win rate (6 calls)
UBS — Reiterated
Buy → Buy 2026-01-08 33% win rate (6 calls)
JP Morgan ↓ Downgrade
Overweight → Neutral 2026-01-07 43% win rate (7 calls)
UBS ↑ Upgrade
Neutral → Buy 2025-09-08 33% win rate (6 calls)
JP Morgan ↑ Upgrade
Neutral → Overweight 2025-09-08 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →